about
The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingMultidisciplinary investigation links backward-speech trait and working memory through genetic mutation.The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide.Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.Structure of the homodimeric androgen receptor ligand-binding domainObesity and prostate cancer research.Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.The role of TET-mediated DNA hydroxymethylation in prostate cancer.Treatment-induced changes in the androgen receptor axis: Liquid biopsies as diagnostic/prognostic tools for prostate cancer.Emerging mechanisms of enzalutamide resistance in prostate cancer.Molecular underpinnings of enzalutamide resistanceEnzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyondDrivers of AR indifferent anti-androgen resistance in prostate cancer cellsEndonuclease FEN1 coregulates ERα activity and provides a novel drug interface in tamoxifen resistant breast cancerIdentification of mineralocorticoid receptor target genes in the mouse hippocampusLoss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasisA CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation
P50
Q27025062-7BC0D4A0-4F39-42F8-B299-11DFB37C7A3CQ27354972-79FE0127-A059-4F08-B2E7-9A52AE05E6C0Q34527336-BC4A87AD-48CE-41A6-90F8-0F95179C59FBQ35108540-26587585-8F2F-43A5-B7BC-A260BF4E5B2EQ37269294-FC96C176-1302-4463-B043-3941B78E578FQ37637859-3F830A59-EC16-42FC-A22A-B4F0CBEF8618Q38838292-E2026802-98DC-411C-9D2A-C3A79D382314Q42252484-93990D0C-A1D7-4FD1-A7FE-8C63638DC774Q47858640-FE651055-1E83-418B-B40F-E6183D301039Q50204094-1162479E-8576-417C-90E5-F3F5823AAF70Q55058538-4ED235C3-E056-406E-9F81-0D4C44F8BEAEQ57280031-8AE7F731-1E38-4890-AD6C-633B0B3C0A89Q58087750-1CABDAE1-03BD-4627-8F07-9587B85774E5Q90262210-E4547BF0-7229-49D9-9B9D-007F2D1F9626Q90469280-03282718-3E1E-4DAF-B493-33EDDF3A0110Q92241778-89AFA38F-DE95-48B4-9B5A-7DDA7F27D6ABQ92322767-1BB7C325-5104-4DC3-A802-B744D65939AAQ92358694-E1EAF573-C45E-44DE-B32A-D666F24A4B54
P50
description
researcher ORCID ID = 0000-0002-7051-9321
@en
name
Stefan Prekovic
@ast
Stefan Prekovic
@en
Stefan Prekovic
@es
Stefan Prekovic
@nl
type
label
Stefan Prekovic
@ast
Stefan Prekovic
@en
Stefan Prekovic
@es
Stefan Prekovic
@nl
prefLabel
Stefan Prekovic
@ast
Stefan Prekovic
@en
Stefan Prekovic
@es
Stefan Prekovic
@nl
P108
P1153
56002109400
P21
P31
P496
0000-0002-7051-9321